chr19-41756936-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002483.7(CEACAM6):c.401C>T(p.Ala134Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,611,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002483.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEACAM6 | NM_002483.7 | c.401C>T | p.Ala134Val | missense_variant | 2/6 | ENST00000199764.7 | |
LOC112268252 | XR_002958447.2 | n.1481G>A | non_coding_transcript_exon_variant | 2/2 | |||
CEACAM6 | XM_011526990.3 | c.401C>T | p.Ala134Val | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEACAM6 | ENST00000199764.7 | c.401C>T | p.Ala134Val | missense_variant | 2/6 | 1 | NM_002483.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152176Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000965 AC: 24AN: 248684Hom.: 0 AF XY: 0.000134 AC XY: 18AN XY: 134270
GnomAD4 exome AF: 0.000134 AC: 195AN: 1459256Hom.: 0 Cov.: 33 AF XY: 0.000146 AC XY: 106AN XY: 725796
GnomAD4 genome AF: 0.000105 AC: 16AN: 152294Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.401C>T (p.A134V) alteration is located in exon 2 (coding exon 2) of the CEACAM6 gene. This alteration results from a C to T substitution at nucleotide position 401, causing the alanine (A) at amino acid position 134 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at